About ScienceIO
ScienceIO is a company based in Boston (United States) founded in 2020 by Gaurav Kaushik was acquired by Veradigm in February 2024. ScienceIO has raised $8 million across 1 funding round from investors including Veradigm, Dorm Room Fund and Will Manidis. The company has 22 employees as of December 31, 2022. ScienceIO offers products and services including Identify, Redact, and Structure. ScienceIO operates in a competitive market with competitors including Causaly, Collaborative Drug Discovery, Qrativ, Kudos and Docphin, among others.
- Headquarter Boston, United States
- Employees 22 as on 31 Dec, 2022
- Founders Gaurav Kaushik
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cascade Bio, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ScienceIO
ScienceIO offers a comprehensive portfolio of products and services, including Identify, Redact, and Structure.
Tool to find and integrate protected health information in medical records.
Removes protected health information from documents for privacy compliance.
Maps medical terms to concepts for enhanced data organization and analysis.
People of ScienceIO
Unlock access to complete
Unlock access to complete
Funding Insights of ScienceIO
ScienceIO has successfully raised a total of $8M through 1 strategic funding round. The most recent funding activity was a Seed round of $8 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ScienceIO
ScienceIO has secured backing from 7 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Veradigm, Dorm Room Fund and Will Manidis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Micro VC investments are directed toward US student-led startups.
|
Locked | Locked | Locked | |
|
Limited information is provided about Sealane Ventures' activities.
|
Locked | Locked | Locked | |
|
Tech startups are funded by S32, a venture capital entity.
|
Locked | Locked | Locked |
Investor details for ScienceIO
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ScienceIO
Investment portfolio details for ScienceIO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ScienceIO
Detailed financials for ScienceIO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scienceio Comparisons
Peer comparison for ScienceIO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ScienceIO
ScienceIO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Causaly, Collaborative Drug Discovery, Qrativ, Kudos and Docphin, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based data-mining tools for scientific evidence discovery are provided.
|
|
| Locked | Locked | Locked |
Biological and chemical data are managed securely in a database.
|
|
| Locked | Locked | Locked |
AI based drug purposing platform to identify treatments for rare diseases
|
|
| Locked | Locked | Locked |
Research communication services are provided to boost visibility and impact.
|
|
| Locked | Locked | Locked |
Medical news and research are personalized for physicians.
|
Detailed competitors of ScienceIO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scienceio
Complete news archive for ScienceIO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ScienceIO
ScienceIO was founded in 2020 and raised its 1st funding round 1 year after it was founded.
ScienceIO is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
ScienceIO is a funded company, having raised a total of $8M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at ScienceIO is 22.
ScienceIO was founded in 2020 and is based in Boston, United States, operating in the healthcare AI sector. Tools are offered to identify and redact protected health information from documents. Medical terms are structured and mapped to standardized concepts. Patient cohorts are selected using unstructured data such as diagnoses and test results. Analysis of patient status, risk factors, and biomarkers is facilitated through these AI-driven processes.
ScienceIO's top competitors include Causaly, BioSymetrics and Collaborative Drug Discovery.
ScienceIO offers Identify, Redact, and Structure.
ScienceIO has 7 investors. Key investors include Veradigm, Dorm Room Fund, Will Manidis, Sealane Ventures, and Lachy Groom.